Position in GTBP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,836
+$1,835 QoQ
Shares Held
4,501
+450000.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GTBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $20,607,106 across 297 Biotechnology names. GTBP ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,803 | $7,056,671 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
36,244 | $2,342,449 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,991 | $2,310,966 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,562 | $1,864,600 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
11,016 | $524,031 | |
| 6 | INCY |
Incyte Corp
|
4,834 | $454,976 | |
| 7 | EXEL |
Exelixis, Inc.
|
10,084 | $432,502 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
7,598 | $429,211 |
All Filings in GTBP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,836 | 4,501 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1 | 1 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1 | 1 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $3 | 1 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2 | 1 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $6 | 2 | Shares | Sole | 2025-01-30 | |
| No filing history on record for this holder in this stock. | ||||||